Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Carmen Ferrajolo, Annalisa Capuano, Gianluca Trifirò, Ugo Moretti, Francesco Rossi & Carmela Santuccio. (2014) Pediatric drug safety surveillance in Italian pharmacovigilance network: an overview of adverse drug reactions in the years 2001 – 2012. Expert Opinion on Drug Safety 13:sup1, pages 9-20.
Read now
Read now
Florian Nigsch, Eugen Lounkine, Patrick McCarren, Ben Cornett, Meir Glick, Kamal Azzaoui, Laszlo Urban, Philippe Marc, Arne Müller, Florian Hahne, David J Heard & Jeremy L Jenkins. (2011) Computational methods for early predictive safety assessment from biological and chemical data. Expert Opinion on Drug Metabolism & Toxicology 7:12, pages 1497-1511.
Read now
Read now
Articles from other publishers (22)
Sara Baldini, Ahmed Khattak, Paolo Capogrosso, Gabriele Antonini, Federico Dehò, Fabrizio Schifano & Nicolò Schifano. (2023) The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database. Brain Sciences 13:12, pages 1652.
Crossref
Crossref
Setyo Utami, Umi Athiyah & Yunita Nita. (2022) Signal detection of adverse drug reaction to first line anti tuberculosis drugs using the Indonesian pharmacovigilance database. Pharmacy Education, pages 270-274.
Crossref
Crossref
Gianluca Trifirò, Valentina Isgrò, Ylenia Ingrasciotta, Valentina Ientile, Luca L’Abbate, Saveria S. Foti, Valeria Belleudi, Francesca Poggi, Andrea Fontana, Ugo Moretti, Riccardo Lora, Alberto Sabaini, Ilenia Senesi, Carla Sorrentino, Maria R. Puzo, Angela Padula, Mariano Fusco, Roberta Giordana, Valentina Solfrini, Aurora Puccini, Paola Rossi, Stefania Del Zotto, Olivia Leoni, Martina Zanforlini, Domenica Ancona, Vito Bavaro, Donatella Garau, Stefano Ledda, Salvatore Scondotto, Alessandra Allotta, Marco Tuccori, Rosa Gini, Giampaolo Bucaneve, David Franchini, Anna Cavazzana, Valeria Biasi, Stefania Spila Alegiani, Marco Massari, Gianluca Trifirò, Ugo Moretti, Riccardo Lora, Alberto Sabaini, Valentina Isgrò, Ylenia Ingrasciotta, Valentina Ientile, Luca L’Abbate, Saveria Serena Foti, Stefania Spila Alegiani, Valeria Belleudi, Francesca Poggi, Andrea Fontana, Marco Massari, Ilaria Andretta, Matilde Tanaglia, Ilenia Senesi, Carla Sorrentino, Maria Rosalia Puzo, Angela Padula, Antonio Carriero, Sergio Sassano, Giovambattista De Sarro, Simona Mirarchi, Caterina Palleria, Caterina Sarro, Mariano Fusco, Roberta Giordana, Marianna Balestrieri, Stefania Rostan, Annalisa Capuano, Francesca Futura Bernardi, Ugo Trama, Alessandro Russo, Maria Grazia Fumo, Valeria Belleudi, Francesca Poggi, Antonio Addis, Felice Musicco, Valentina Solfrini, Ester Sapigni, Aurora Puccini, Ilaria Mazzetti, Debora Podetti, Anna Maria Potenza, Victoria Nikitina, Rita Ricciardelli, Nazanin Mogheiseh, Silvia Croce, Paola Rossi, Aba Pettinelli, Stefania Del Zotto, Lucian Ejlli, Olivia Leoni, Ida Fortino, Michele Ercolanoni, Arianna Mazzone, Andrea Nisic, Simone Schiatti, Monica Ludergnani, Martina Zanforlini, Mauro Mancini, Luigi Patregnani, Paolo Fabbietti, Elisa Antonicelli, Antea Mangano, Annalisa Campomori, Silvana Annamaria Urru, Giorgio Costa, Giovanni M Guarrera, Domenica Ancona, Vito Bavaro, Paolo Stella, Donatella Garau, Enrico Serra, Stefano Ledda, Paolo Carta, Salvatore Scondotto, Alessandra Allotta, Rosa Gini, Marco Tuccori, Alfredo Vannacci, Ersilia Lucenteforte, Maria Parrilli, Irma Convertino, Giampaolo Bucaneve, Marcello De Giorgi, David Franchini, Rosalba Elisabetta Rocchi, Mariangela Rossi, Giovanna Scroccaro, Anna Cavazzana, Valeria Biasi, Paola Deambrosis, Giampietro Grindelli & Eliana Ferroni. (2021) Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project. BioDrugs 35:6, pages 749-764.
Crossref
Crossref
Avirup Guha, Merna Armanious & Michael G. Fradley. (2019) Update on cardio-oncology: Novel cancer therapeutics and associated cardiotoxicities. Trends in Cardiovascular Medicine 29:1, pages 29-39.
Crossref
Crossref
Ariane G. S. Araujo, Helena H. L. Borba, Fernanda S. Tonin, Luana Lenzi, Rafael Venson, Roberto Pontarolo & Astrid Wiens. (2018) Safety of Biologics Approved for the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases: A Disproportionality Analysis from the FDA Adverse Event Reporting System (FAERS). BioDrugs 32:4, pages 377-390.
Crossref
Crossref
Alexandra C. Pacurariu, Christina E. Hoeve, Peter Arlett, Georgy Genov, Jim Slattery, Miriam C.J.M. Sturkenboom & Sabine M.J.M. Straus. (2017) Is patient exposure preapproval and postapproval a determinant of the timing and frequency of occurrence of safety issues?. Pharmacoepidemiology and Drug Safety 27:2, pages 168-173.
Crossref
Crossref
Emanuel Raschi, Elisabetta Poluzzi, Francesco Salvo, Ariola Koci, Marc Suling, Stefania Antoniazzi, Luisella Perina, Lorna Hazell, Ugo Moretti, Miriam Sturkenboom, Edeltraut Garbe, Antoine Pariente & Fabrizio De Ponti. (2015) The Contribution of National Spontaneous Reporting Systems to Detect Signals of Torsadogenicity: Issues Emerging from the ARITMO Project. Drug Safety 39:1, pages 59-68.
Crossref
Crossref
Magnus Lerch, Peter Nowicki, Katrin Manlik & Gabriela Wirsching. (2015) Statistical Signal Detection as a Routine Pharmacovigilance Practice: Effects of Periodicity and Resignalling Criteria on Quality and Workload. Drug Safety 38:12, pages 1219-1231.
Crossref
Crossref
Sandra de Bie, Carmen Ferrajolo, Sabine M. J. M. Straus, Katia M. C. Verhamme, Jan Bonhoeffer, Ian C. K. Wong & Miriam C. J. M. Sturkenboom. (2015) Pediatric Drug Safety Surveillance in FDA-AERS: A Description of Adverse Events from GRiP Project. PLOS ONE 10:6, pages e0130399.
Crossref
Crossref
Gianmario Candore, Kristina Juhlin, Katrin Manlik, Bharat Thakrar, Naashika Quarcoo, Suzie Seabroke, Antoni Wisniewski & Jim Slattery. (2015) Comparison of Statistical Signal Detection Methods Within and Across Spontaneous Reporting Databases. Drug Safety 38:6, pages 577-587.
Crossref
Crossref
L. Faisandier, A. Fouillet, D.J. Bicout, F. Golliot, I. Ahmed, S. Bringay & D. Eilstein. (2015) Surveillance et détection des événements inhabituels en toxicovigilance : revue des méthodes pertinentes. Revue d'Épidémiologie et de Santé Publique 63:2, pages 119-131.
Crossref
Crossref
G. Trifirò, P. M. Coloma, P. R. Rijnbeek, S. Romio, B. Mosseveld, D. Weibel, J. Bonhoeffer, M. Schuemie, J. van der Lei & M. Sturkenboom. (2014) Combining multiple healthcare databases for postmarketing drug and vaccine safety surveillance: why and how?. Journal of Internal Medicine 275:6, pages 551-561.
Crossref
Crossref
Gianluca Trifirò & Preciosa Coloma. 2014. Mann's Pharmacovigilance. Mann's Pharmacovigilance
439
451
.
Nigel SB Rawson & Jorge A Ross Terres. (2013) Rosiglitazone use and associated adverse event rates in Canada between 2004 and 2010. BMC Research Notes 6:1.
Crossref
Crossref
James H. Lewis. (2013) Drug-Induced Liver Injury Throughout the Drug Development Life Cycle: Where We Have Been, Where We are Now, and Where We are Headed. Perspectives of a Clinical Hepatologist. Pharmaceutical Medicine 27:3, pages 165-191.
Crossref
Crossref
Preciosa M. Coloma, Gianluca Trifirò, Martijn J. Schuemie, Rosa Gini, Ron Herings, Julia Hippisley-Cox, Giampiero Mazzaglia, Gino Picelli, Giovanni Corrao, Lars Pedersen, Johan van der Lei & Miriam Sturkenboom. (2012) Electronic healthcare databases for active drug safety surveillance: is there enough leverage?. Pharmacoepidemiology and Drug Safety 21:6, pages 611-621.
Crossref
Crossref
V. Strand, D.A. Bloch, R. Leff, P.M. Peloso & L.S. Simon. (2011) Safety issues in the development of treatments for osteoarthritis: recommendations of the Safety Considerations Working Group. Osteoarthritis and Cartilage 19:5, pages 493-499.
Crossref
Crossref
Carlo Piccinni, Chiara Sacripanti, Elisabetta Poluzzi, Domenico Motola, Lara Magro, Ugo Moretti, Anita Conforti & Nicola Montanaro. (2009) Stronger association of drug-induced progressive multifocal leukoencephalopathy (PML) with biological immunomodulating agents. European Journal of Clinical Pharmacology 66:2, pages 199-206.
Crossref
Crossref
K. N. Woodward. 2009. Veterinary Pharmacovigilance. Veterinary Pharmacovigilance
659
672
.
AP Chiang & AJ Butte. (2009) Data-Driven Methods to Discover Molecular Determinants of Serious Adverse Drug Events. Clinical Pharmacology & Therapeutics 85:3, pages 259-268.
Crossref
Crossref
Miles Hacker. 2009. Pharmacology. Pharmacology
327
352
.
Allen D. Roses. (2008) Pharmacogenetics in drug discovery and development: a translational perspective. Nature Reviews Drug Discovery 7:10, pages 807-817.
Crossref
Crossref